Aggregated China Business Blogs



Immtech Conducts Pneumonia Drug Trials on the Fast Track

Aggregated Source: China Stocks News and Analysis from Seeking Alpha
December 2, 2007|


Immtech Pharmaceuticals (IMM) has enlisted Jubo Liu, PhD, to serve as Development Liaison for Clinical Trials in China. Currently, Immtech is conducting a Phase III trial of pafuramidine as a treatment for pneumocystis pneumonia [PCP, a fungal infection affecting patients with compromised immune systems.

Original URL: Click here to visit original article
Copyright China Stocks News and Analysis from Seeking Alpha

Print This Post Print This Post | Email This Page Email This Page
No Ratings Yet
Loading ... Loading ...

Related Info:
  • Sunway and Genzyme to Collaborate on Gene Therapy
  • China Biologic Receives SFDA Approval For Clinical Trials Of FVIII
  • China Biologic Receives SFDA Approval For Clinical Trials Of FVIII
  • China Pushes Ahead of India in Clinical Trials
  • Immtech Pharma to Start JV with Beijing Capital Medical University

    • No Comments Yet »

    Your comment

    The following HTML tags are permitted:
    <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <code> <em> <i> <strike> <strong>

    RSS RSS Feed for Comments on this Post |